How will Australia's traditional approach to health technology assessment manage a multi-million dollar one-time injection with the 'potential' to cure and add 40, 50, 60 or even 70 years of normal life expectancy? The US could lead the way. …
Do you value a lifetime benefit based on almost no evidence?
May 29, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
The cost of immunoglobulin is on the rise
June 27, 2019 - - Latest News -
NZ's myeloma patients rely on hope - and everything else besides PHARMAC
June 27, 2019 - - Latest News -
Does PHARMAC serve patients or its ideological self?
June 27, 2019 - - Latest News -
NICE's Dillon: Change required to manage the coming 'revolution in medicines'
June 27, 2019 - - Latest News -
MA: More required to attract emerging therapies
June 26, 2019 - - Latest News -
Recognition for Sanofi's employee well-being program
June 26, 2019 - - Latest News -
NZ: Poor access and poor outcomes
June 26, 2019 - - Latest News